Latest News about AZN
Recent news which mentions AZN
2 Market-Beating Stocks to Buy in 2023 and Hold Forever
December 24, 2022
From Motley Fool
The Top Healthcare Stocks to Buy With $100
December 22, 2022
From Motley Fool
Europe Approves AstraZeneca's Two Combo Therapies For Prostate, Bile Duct Cancer Settings
December 21, 2022
From Benzinga
Top M&A Target: Madrigal Pharmaceuticals Could Be Next After Successful NASH Data, Analyst Says
December 20, 2022
From Benzinga
Could AstraZeneca's Asthma Drug Candidate Generate Billions?
December 20, 2022
From Motley Fool
AstraZeneca - Daiichi Sankyo's Enhertu Wins European Approval For Gastric Cancer, CHMP Backs Other Cancer Drugs
December 19, 2022
From Benzinga
From Benzinga
AstraZeneca’s Forxiga gets EU approval recommendation for symptomatic chronic heart failure
December 19, 2022
Tickers
AZN
From MarketWatch
AstraZeneca’s Imfinzi plus Imjudo recommended for approval in the EU
December 19, 2022
Tickers
AZN
From MarketWatch
Guardant Health (GH) Stock Sinks on Disappointing Blood Test Results
December 16, 2022
From InvestorPlace
2 Best Biotech Stocks to Buy Right Now
December 16, 2022
From Motley Fool
From Benzinga
Netflix, Workday, Costco, Caterpillar and more: These stocks are Cowen’s favorites for 2023
December 10, 2022
From MarketWatch
2 Top Healthcare Stocks to Buy for the Long Haul
December 09, 2022
From Motley Fool
AstraZeneca Highlights First Results From Datopotamab Study In Pretreated Breast Cancer Patients
December 09, 2022
From Benzinga
AstraZeneca Highlights Detailed Data From Two Breast Cancer Trials
December 08, 2022
From Benzinga
AstraZeneca's Enhertu Cuts Risk Of Death By 36% VsTrastuzumab In Metastatic Breast Cancer
December 07, 2022
From Benzinga
US Supports Delay On COVID Patent Waiver Extension Decision
December 06, 2022
From Benzinga
Is Amgen Stock a Buy for Income Investors?
December 02, 2022
From Motley Fool
2 Stocks That Could Surprise Investors in 2023
December 01, 2022
From Motley Fool
Why Shares of Compugen Rose 16.5% on Wednesday
November 30, 2022
From Motley Fool
Analyst Says Coinbase 'A Waste Of Time', Taylor Swift's Concert Fiasco Under DOJ Probe, Shopify Clocks Record Black Friday Sales: Top Stories Monday, Nov. 28
November 28, 2022
From Benzinga
AstraZeneca Bets On UK Listed Firm For Lung Diseases
November 28, 2022
From Benzinga
From Benzinga
2 Breakout Growth Stocks to Buy for the Long Haul
November 19, 2022
From Motley Fool
2 Stocks to Buy Whether or Not a Recession Is Coming
November 18, 2022
From Motley Fool
Why Shares of Compugen Jumped 17.86% on Thursday
November 17, 2022
From Motley Fool
How Long Can This Top Stock Continue Defying the Bear Market?
November 17, 2022
From Motley Fool
Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says
November 16, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
